By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Chemin Messidor 5-7
Case Postale 5911
Lausanne    CH - 1002  Switzerland
Phone: 41-21-321-0111 Fax: 41-21-321-0169


Company News
Debiopharm's Partner Yakult Honsha Announces Elplat Approbation In Gastric Cancer In Japan 11/24/2015 6:41:16 AM
Debiopharm Presents Positive Preliminary Results From Phase 1 Trials In The Development Of The IAP Inhibitor Debio 1143 At The 27th EORTC-National Cancer Institute-AACR Symposium In Boston 11/3/2015 6:31:27 AM
The Japanese Cancer Association And Debiopharm Announce Winners Of The 2015 JCA-Mauvernay Award 10/9/2015 10:12:52 AM
Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy 9/8/2015 6:56:36 AM
Debiopharm Acquires FibroTrap Sample Processing Technology From Spinomix 6/16/2015 9:32:39 AM
Debiopharm Announces Phase III Positive Results For Triptorelin 6-Month Formulation In The Management Of Central Precocious Puberty (CPP) 5/19/2015 6:22:16 AM
Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1450 In Staphylococcal Skin Infections 4/23/2015 9:01:14 AM
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015 11:07:17 AM
Debiopharm Regains Full Rights To Alisporivir Program 1/12/2015 7:16:22 AM
FDA Grants Fast Track Designation To Debiopharm's Antibiotic Debio 1450 1/8/2015 7:57:38 AM